Fas-Fas ligand-mediated apoptosis within aqueous during idiopathic acute anterior uveitis

Investigative Ophthalmology and Visual Science

Volumn 40, Issue 10, 1999, Pages 2258-2267

  Dick, Andrew D ^a   Siepmann, Kirsten ^a   Dees, Chrisjan ^a   Duncan, Linda ^a   Broderick, Cathryn ^a   Liversidge, Janet ^a   Forrester, John V ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD45 ANTIGEN; CD69 ANTIGEN; FAS ANTIGEN; FAS LIGAND; INTERLEUKIN 2 RECEPTOR;

ANTIGEN EXPRESSION; APOPTOSIS; AQUEOUS HUMOR; ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOREGULATION; IRIDOCYCLITIS; LEUKEMIA CELL LINE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0032819795     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Forrester JV, McMenamin PG, Holthouse I, Lumsden L, Liversidge J. Localization and characterization of major histocompatibility complex class II-positive cells in the posterior segment of the eye: implications for induction of autoimmune uveoretinitis. Invest Ophthalmol Vis Sci. 1994;35:64-77.
2. McMenamin PG, Crewe J, Morrison S, Holt PG. Immunomorphologic studies of macrophages and MHC class II+ dendritic cells in the iris and ciliary body of the rat, mouse and human eye. Invest Opbthalmol Vis Sci. 1994;35:3234-3250.
3. Steptoe RJ, Holt PG, McMenamin PG. Functional studies of major histocompatibility class II-positive dendritic cells and resident tissue macrophages isolated from the rat iris. Immunology. 1995;85: 630-637.
4. Egan RM, Yorkey C, Black R, Loh WK, Stevens JL, Woodward JG. Peptide-specific T cell clonal expansion in vivo following immunization in the eye, an immunoprivileged site. J Immunol. 1996;157: 2262-2271.
5. Streilein JW. Molecular basis of ACAID. Ocul Immunol Inflamm. 1997;5:217-218.
6. Ferguson TA. The molecular basis of anterior associated immune deviation (ACAID). Ocul Immunol Inflamm. 1997;5:213-215.
7. Griffith TS, Ferguson TA. The role of FasL-induced apoptosis in immune privilege. Immunol Today. 1997;18:240-244.
8. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science. 1995;270:1189-1192.
9. Ferguson TA, Gao Y, Herndon JM, Griffith TS. Apoptotic cell death and IL-10 production in the eye are essential for the induction of immune deviation [ARVO Abstract]. Invest Ophthalmol Vis Sci. 1997;38(4):S492. Abstract nr 2270.
10. Griffith TS, Yu X, Herndon JM, Green DR, Ferguson TA. CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. Immunity. 1996;5:7-16.
11. Kawashima H, Yamagami S, Tsuru T, Gregerson DS. Anterior chamber inoculation of splenocytes without Fas/Fas-ligand interaction primes for a delayed-type hypersensitivity response rather than inducing anterior chamber-associated immune deviation. Eur J Immunol. 1997;27:2490-2494.
12. Kang SM, Schneider DB, Lin Z, et al. Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction. Nat Med. 1997;3:738-743.
13. Stuart PM, Griffith TS, Usui N, Pepose J, Yu X, Ferguson TA. CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. J Clin Invest. 1997;99:396-402.
14. Forrester JV. Uveitis: pathogenesis. Lancet. 1992;388:1498-1501.
15. Forrester JV, Liversidge J, Dua HS, Towler H, McMenamin PG. Comparison of clinical and experimental uveitis. Curr Eye Res. 1990;9:75-84.
16. Feltkemp TE, Ringrose JH. Acute anterior uveitis and spondyloarthropathies. Curr Opin Rheumatol. 1998;10:314-318.
17. Forrester JV. Duke Elder lecture: new concepts on the role of autoimmunity in the pathogenesis of uveitis. Eye. 1992;5:433-447.
18. Deschennes J, Freeman WR, Char DH, Garavoy MR. Lymphocyte subpopulations in uveitis. Arch Ophthalmol. 1986;104:233-236.
19. Muhaya M, Calder V, Towler HM, Shaer B, McLaughlan M, Lightman S. Characterisation of T cells and cytokines in the aqueous humour (AH) in patients with Fuch's heterochromic cyclitis (FHC) and idiopathic anterior uveitis. Clin Exp Immunol. 1998;111:123-128.
20. Ohta K, Norose K, Wang XC, Ito S, Yoshimura N. Abnormal naive and memory T lymphocyte subsets in the peripheral blood of patients with uveitis. Curr Eye Res. 1997;16:650-655.
21. Ohta K, Norose K, Wang XC, Susuma I, Yano A, Segawa K. Apoptosis-related Fas antigen on memory T cells in aqueous humor of uveitic patients. Curr Eye Res. 1996;15:299-306.
22. Van der Lelij A, Rothova A. Diagnostic anterior chamber paracentesis in uveitis: a safe procedure? BrJ Ophthalmol. 1997;81:976-979.
23. Gavriele Y, Sherman Y. Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992;119:493-501.
24. Verities I, Haansen H, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis: flow cytometric detection of phosphatidylerine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods. 1995;184:39-51.
25. Lenardo MJ. Fas and the art of lymphocytic maintenance. J Exp Med. 1996;183:721-724.
26. Ohta K, Yoshimura N. Expression of Fas antigen on helper T lymphocytes in Vogt-Koyanagi-Harada disease. Graefes Arch Clin Exp Ophthalmol. 1998;236:434-439.
27. Ziegler SF, Ramsdell F, Alderson MR. The activation antigen CD69. Stem Cells. 1994;12:456-465.
28. Biselli R, Matricardi PM, D'Amelio R, Fattorossi A. Multiparametric flow cytometric analysis of the kinetics of surface molecule expression after polyclonal activation of human peripheral blood T lymphocytes. Scand J Immunol. 1992;35:439-447.
29. Smith JR, Hart PH, Coster DJ, Williams KA. Mice deficient in tumor necrosis factor receptors p55 and p75, interleukin-4, or inducible nitric oxide synthase are susceptible to endotoxin-induced uveitis. Invest Ophthalmol Vis Sci. 1998;39:658-661.
30. Tanaka M, Suda T, Takahashi T, Nagata S. Expression of the functional form of human Fas ligand in activated lymphocytes. EMBO J. 1995;14:1129-1135.
31. Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand: a novel member of the tumour necrosis factor family. Cell. 1993;75:1169-1187.
32. Gearing AJH, Beckett P, Christodoulou M, et al. Processing of tumour necrosis factor-α precursor by metalloproteinases Nature. 1994;370:555-557.
33. Kayagaki N, Kawasaki A, Ebata T, et al. Metalloproteinase-mediated release of human Fas ligand. J Exp Med. 1995;182:1777-1783.
34. Suda T, Hashimoto H, Tanaka M, Ochi T, Nagata S. Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing. J Exp Med. 1997;186:2045-2050.
35. Schneider P, Holler N, Bodmer JL, et al. Conversion of membrane-bound Fas (CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J Exp Med. 1998;187:1205-1213.
36. Di Girolamo N, Verma MJ, McCluskey PJ, Lloyd A, Wakefield D. Increased matrix metalloproteinases in the aqueous humour of patients and experimental animals with uveitis. Curr Eye Res. 1996;15:1060-1068.
37. De Vos AF, Van Haren MAC, Verhagen C, Hoekzema R, Kijlstra A. Kinetics of intraocular tumor necrosis factor and interleukin-6 in endotoxin induced uveitis in the rat. Invest Ophthalmol Vis Sci. 1994;35:1100-1106.
38. Yoshida M, Yoshimura N, Hangai M, Tanihara H, Honda Y. Interleukin-1a, interleukin-1b and tumor necrosis factor gene expression in endotoxin induced uveitis. Invest Ophthalmol Vis Sci. 1994;35:1107-1113.
39. Kasner L, Chan CC, Whitcup SM, Gery I. The paradoxical effect of tumor necrosis factor alpha (TNF-α) in endotoxin induced uveitis. Invest Ophthalmol Vis Sci. 1993;34:2911-2917.
40. Osborne GR. Apoptosis and the maintenance of homeostasis in the immune system. Curr Opin Immunol. 1996;8:245-254.
41. Bakunowicz-Lazaraczyk A, Moniuszko T, Sredzinska-Kita D, Chwiecko J. Levels of selected cytokines in aqueous humor of patients with cataract extraction. Klin Oczna. 1997;99:235-237.
42. Cope AP, Liblau RS, Yang XD, et al. Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling. J Exp Med. 1997;185:1573-1584.
43. Jewett A, Cavalcanti M, Bonavida B. Pivotal role of endogenous TNF-α in the induction of functional inactivation and apoptosis in NK cells. J Immunol. 1997;159:4815-4822.
44. Kabelitz D. Apoptosis, graft rejection and transplant tolerance. Transplantation. 1998;65:869-875.
45. Wever PC, Boonstra JG, Laterveer JC, et al. Mechanisms of lymphocyte-mediated cytotoxicity in acute renal allograft rejection. Transplantation. 1998;66:259-264.
46. D'Orazio TJ, Niederkorn JY. A novel role forTGF-β and IL-10 in the induction of immune privilege. J Immunol. 1998;160:2089-2098.
47. + T cells. J Exp Med. 1996;184:19-29.
48. Gao Y, Herndon JM, Zhang H, Griffith TS, Ferguson TA. Antiinflammatory effects of CD95 Ligand (FasL)-induced apoptosis. J Exp Med. 1998;188:887-896.
49. Ramsdell F, Seaman MS, Miller RE, Picha KS, Kennedy MK, Lynch DH. Differential ability of Th1 and Th2 cells to undergo activation-induced cell death. Int Immunol. 1994;6:1545-1553.
50. + type 2 cells. J Exp Med. 1995;181:5-7.
51. Verma MJ, Lloyd A, Rager H, et al. Chemokines in acute anterior uveitis. Curr Eye Res. 1997;16:1202-1208.
52. Leuenroth S, Lee C, Grutkoski P, Keeping H, Simms HH. Interleukin-8-induced suppression of polymorphonuclear leukocyte apoptosis is mediated by suppressing CD95 (Fas/Apo-1) Fas-1 interactions. Surgery. 1998;124:409-417.
53. Vermes I, Haansan H, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis: flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods. 1995;184:39-51.